Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Ally Financial
ALLY
5
Bank of America
BAC
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 126.68%44.81M | 558.06%5.23M | 256.04%737K | 235.79%14.9M | 67.13%23.95M | 3,869.48%19.77M | -76.00%794K | -93.47%207K | 170.55%4.44M | 288.11%14.33M |
Net profit before non-cash adjustment | -226.09%-17.16M | -1,700.60%-18.74M | -326.06%-2.19M | 161.59%3.25M | 124.34%517K | 77.72%-5.26M | 110.78%1.17M | 164.42%967K | 12.86%-5.28M | 59.11%-2.12M |
Total adjustment of non-cash items | -38.96%10M | -26.76%9.19M | 103.56%232K | -95.34%261K | -93.25%321K | -34.86%16.39M | 5.62%12.55M | -241.92%-6.51M | 29.25%5.6M | 9.15%4.76M |
-Depreciation and amortization | 26.73%422K | 53.85%120K | 42.17%118K | 27.06%108K | -12.64%76K | -9.76%333K | -11.36%78K | -9.78%83K | -9.57%85K | -8.42%87K |
-Reversal of impairment losses recognized in profit and loss | --0 | ---- | ---- | ---- | ---- | -166.06%-1.31M | ---- | ---- | ---- | ---- |
-Assets reserve and write-off | 2.62%9.25M | ---- | ---- | ---- | ---- | 525.38%9.02M | ---- | ---- | ---- | ---- |
-Disposal profit | 400.00%30K | 100.74%43K | --0 | ---- | ---- | 74.36%-10K | -14,733.33%-5.79M | --5.78M | ---- | ---- |
-Other non-cash items | -96.44%297K | -102.16%-228K | 101.56%114K | -63.52%166K | -94.75%245K | -60.98%8.35M | 25.18%10.54M | -263.00%-7.31M | -89.26%455K | 9.55%4.67M |
Changes in working capital | 501.30%51.97M | 304.72%14.78M | 5,282.00%2.69M | 176.68%11.39M | 97.61%23.11M | 928.67%8.64M | -414.42%-7.22M | -36.71%50K | 22.32%4.12M | 272.43%11.7M |
-Change in receivables | 249.63%41.62M | 70.96%-3.8M | 48.56%-5.1M | 402.89%39.31M | 37.68%11.21M | -60.72%-27.82M | 23.24%-13.08M | -516.53%-9.91M | -522.10%-12.98M | 1,546.18%8.14M |
-Change in inventory | 14.70%60.73M | -43.03%25.14M | 377.82%15.04M | -115.68%-1.69M | 546.19%22.24M | -31.12%52.95M | -32.35%44.12M | -127.26%-5.42M | 2,298.98%10.8M | 144.55%3.44M |
-Change in payables | -36.29%-41.12M | 105.20%2.7M | -147.22%-7.26M | -516.53%-26.23M | -9,332.14%-10.34M | 50.21%-30.17M | -13.21%-51.95M | 169.35%15.37M | 5.96%6.3M | -92.57%112K |
-Changes in other current assets | -167.70%-9.27M | ---- | ---- | ---- | ---- | 342,025.00%13.69M | ---- | ---- | ---- | ---- |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | ||||||||||
Interest received (cash flow from operating activities) | ||||||||||
Tax refund paid | -1,522.11%-1.35M | -1,521.43%-681K | -2,292.31%-285K | -199.18%-242K | -19.17%-143K | 112.13%95K | 54.84%-42K | 127.66%13K | 140.46%244K | -200.00%-120K |
Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 135.90%615K | -615K |
Operating cash flow | 118.80%43.46M | 504.26%4.54M | 105.45%452K | 176.76%14.66M | 75.12%23.81M | 7,069.47%19.86M | -76.61%752K | -95.45%220K | 1,960.70%5.3M | 258.25%13.6M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -13,717.39%-3.18M | 422.22%29K | 90.00%-2K | -28,763.64%-3.15M | -940.00%-52K | -179.31%-23K | -125.00%-9K | -566.67%-20K | 375.00%11K | ---5K |
Net investment product transactions | -161.21%-71K | -136.36%-4K | -217.65%-20K | -212.96%-61K | -58.82%14K | -97.42%116K | -99.76%11K | --17K | --54K | --34K |
Interest received (cash flow from investment activities) | 2.11%630K | -8.05%354K | 4.60%91K | 45.07%103K | 10.81%82K | -32.42%617K | 16.67%385K | -55.84%87K | -71.83%71K | -44.78%74K |
Investing cash flow | -468.87%-2.62M | -2.07%379K | -17.86%69K | -2,387.50%-3.11M | -57.28%44K | -86.95%710K | -92.04%387K | -56.70%84K | -45.16%136K | -23.13%103K |
Financing cash flow | ||||||||||
Net issuance payments of debt | 77.37%-3.68M | --0 | 166.57%7.71M | -146.35%-7.83M | 75.31%-3.55M | 62.46%-16.25M | 82.73%-1.57M | 119.35%2.89M | 71.49%-3.18M | -77.53%-14.39M |
Net preferred stock issuance | -850.95%-9.5M | --0 | -100.00%-2M | --0 | ---7.5M | -111.75%-999K | -99.99%1K | ---1M | --0 | --0 |
Increase or decrease of lease financing | ---88K | ---11K | ---22K | ---33K | ---22K | --0 | --0 | --0 | --0 | --0 |
Interest paid (cash flow from financing activities) | -17.40%-7.83M | -55.62%-2.8M | -75.23%-3.19M | 93.15%-167K | -172.52%-1.68M | 10.24%-6.67M | 63.89%-1.8M | -146.08%-1.82M | ---2.44M | ---615K |
Net other fund-raising expenses | -195.06%-5.02M | 232.99%2.96M | -132.34%-2.97M | -94.40%-2.5M | -553.51%-2.52M | -80.21%5.29M | 53.10%-2.23M | 224.61%9.18M | -107.90%-1.29M | -103.12%-385K |
Financing cash flow | -40.20%-26.12M | 102.68%150K | -105.08%-470K | -52.59%-10.53M | 0.81%-15.27M | -19.85%-18.63M | 45.69%-5.59M | 171.94%9.25M | -303.84%-6.9M | -464.91%-15.39M |
Net cash flow | ||||||||||
Beginning cash position | 98.78%3.91M | 62.20%13.56M | 1,228.40%13.51M | 4,476.19%12.49M | 98.78%3.91M | -84.08%1.97M | 81.52%8.36M | -109.62%-1.2M | -96.81%273K | -84.61%1.97M |
Current changes in cash | 657.64%14.72M | 214.03%5.07M | -99.47%51K | 168.98%1.01M | 606.67%8.58M | 118.70%1.94M | -101.22%-4.45M | 222.01%9.56M | -137.78%-1.47M | 60.04%-1.69M |
End cash Position | 376.50%18.63M | 376.50%18.63M | 62.20%13.56M | 1,228.40%13.51M | 4,476.19%12.49M | 98.78%3.91M | 98.78%3.91M | 81.52%8.36M | -109.62%-1.2M | -96.81%273K |
Free cash flow | 102.85%40.21M | 508.91%4.51M | 125.00%450K | 117.18%11.49M | 74.80%23.76M | 6,819.32%19.82M | -76.93%741K | -95.86%200K | 1,991.30%5.29M | 258.19%13.59M |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.